News List

LifeCell inherits Cryo-Save India’s preserved umbilical cord stem cell samples


The cryopreserved stem cells currently under the care of Cryo-Save would be transported to LifeCell’s preservation facility at Chennai.

By Team ABLE

Chennai-headquartered umbilical cord stem cell bank LifeCell has recently announced signing of a formal agreement with Cryo-Save India (Cryo-Save) for formal transfer of all of its 18,000 cryopreserved umbilical cord units and corresponding customer agreements to LifeCell.

The cryopreserved stem cells currently under the care of Cryo-Save would be transported to LifeCell’s preservation facility at Chennai. This transportation would occur in phases and is expected to take up to 3 months for completion.

Speaking on the occasion Mayur Abhaya, MD, CEO, LifeCell said, “This transfer marks an important step to expand our business by leveraging our infrastructure and storage standards. It would also further strengthen our endeavor of becoming the country’s largest registry of cord blood stem cells. We are happy to welcome these 18,000 families into the ambit of our community and also extend benefits such as complete family protection and unlimited access to matching stem cells. We look forward to providing best in class service to the new members of the LifeCell family.”